| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 164,891 | 171,353 | 173,597 | 199,110 | | Cost of Revenue | 45,156 | 49,541 | 54,843 | 65,646 | | | Gross Profit |
-
| 121,812 | 118,754 | 133,464 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 89,529 | 138,227 | 88,202 | 525,895 | | Non Recurring |
-
| (748) | 748 | (184,553) | | Others | 224,179 | 127,092 | 146,872 | 124,550 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (142,759) | (117,068) | (332,428) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (193,973) | (142,759) | (117,068) | (332,428) | | Interest Expense | 6,227 | 6,564 | 7,041 | 10,946 | | Income Before Tax | (200,200) | (149,323) | (124,109) | (343,374) | | Income Tax Expense | 123,304 | (59,647) | (49,706) | (33,435) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (323,504) | (89,676) | (74,403) | (309,939) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (323,504) | (89,676) | (74,403) | (309,939) | | Preferred Stock And Other Adjustments | (17,251) | (21,809) | (16,408) | (9,421) | | | Net Income Applicable To Common Shares | ($340,755) | ($111,485) | ($90,811) | ($319,360) |
|
0.51% Nasdaq 
0.018 (2.65%) 
Income Statement
